Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1947399 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Letter: Development of a Novel Prediction Tool for Response to First-Line Treatments of Monosymptomatic Nocturnal Enuresis: A Randomized, Controlled, International, Multicenter Study (DRYCHILD).
J Urol
January 2025
Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá, Colombia.
Impact of nocturnal road traffic noise and annoyance on self-reported insomnia symptoms: policy intervention in noise-polluted environments.
Environ Monit Assess
January 2025
Department of Civil Engineering, National Institute of Technology, Mizoram, India.
Chronic exposure to traffic noise is associated with increased stress and sleep disruptions. Research on the health consequences of environmental noise, specifically traffic noise, has primarily been conducted in high-income countries (HICs), which have guided the development of noise regulations. The relevance of these findings to policy frameworks in low- and middle-income countries (LMICs) remains uncertain.
View Article and Find Full Text PDFSocial Determinants of Health and Nocturnal Hypertension in the Chronic Renal Insufficiency Cohort.
Am J Kidney Dis
January 2025
Renal-Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Subcutaneous administration of foslevodopa/foscarbidopa (PRODUODOPA) in arm and thigh due to giant epigastric hernia: a case report.
Neurol Sci
December 2024
Department of Neurology, General Hospital dr. Ivo Pedišić, Josipa Jurja Strossmayera 59, Sisak, 44000, Croatia.
Background: PRODUODOPA is a combination of foscarbidopa and foslevodopa indicated for the treatment of motor fluctuations in patients with advanced Parkinson's disease when available combinations of peroral drugs have not given satisfactory results. The solution is administered via subcutaneous infusion, most frequently in the abdomen, using an infusion pump. The study results showed a significant effect on the reductions in off time and higher control of motor symptoms without troublesome dyskinesia.
View Article and Find Full Text PDFThe Importance of Controlling Terminal Complement Activity and Intravascular Hemolysis in Paroxysmal Nocturnal Hemoglobinuria (PNH).
Am J Hematol
December 2024
Alexion, AstraZeneca Rare Disease, Boston, Massachusetts, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!